3557 results for «238»
3557 results
Case-based learning for the Heart Team: patient selection for tricuspid valve interventions
18 Nov 2019 – From PCR London Valves 2019
Consult this session on patient selection for tricuspid valve interventions to gain insights into how clinical and anatomical characteristics influence patient and device selection, and to become more familiar with the key steps in transcatheter tricuspid valve procedures.
Case-based learning for the Heart Valve Team: TAVI in pure aortic regurgitation
19 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI in pure aortic regurgitation to learn more about the anatomy and pathophysiology of aortic regurgitation, the current and emerging surgical treatment options, and the potential role of TAVI in this patient group and how to identify potential candidates for transcatheter intervention.
Heart Team 2.0 in action: TAVI or SAVR in younger lower-risk patients?
18 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI vs SAVR in younger lower-risk patients to learn all about the outcomes of various recent trials and how to translate them into your clinical practice, thanks to a selection of challenging cases involving bicuspid aortic valve disease, small aortic annulus, and complex...
The Heart Team 2.0 – Where will we be in 2030?
19 Nov 2019 – From PCR London Valves 2019
Consult this session on the Heart Team 2.0 to gain insight into what the future holds for cardiologists, based on clinical evidence, trends in structural heart disease, artificial intelligence, 3D printing, and more!
Complications of TAVI and SAVR - Hosted by Greece, Japan, UK and the USA
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the management of complications of TAVI and SAVR, thanks to a selection of challenging cases, such as: post-TAVR Gerbode defect, aortic dissection complicated by infective endocarditis after TAVI, TAVR with SAPIEN 3 for very large annulus complicated by late severe paravalvular leak, percutaneous...
TAVI: novel peri-procedural imaging techniques
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about the novel peri-procedural imaging techniques for TAVI, and discover the impact of initial Evolut TAVR deployment orientation on final valve orientation and coronary re-access, the prognostic value of diastolic flow reversal on clinical outcomes after TAVR, and more!
What will be relevant for TAVI assessment in 2020?
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about what will be relevant for TAVI assessment in 2020: key imaging requirements before referral to the Heart Team, which patients may need a pacemaker and when it should be implanted, how modern Heart Teams should function, and more!
TAVI: clinical assessment and early post-procedural discharge
18 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI to gain insight into various registries and trials regarding clinical assessment and early post-procedural discharge, such as the FIFA-trial, the VICTORY-registry, the FAST TAVI trial, and more!
PCR London Valves Closing Ceremony
19 Nov 2019 – From PCR London Valves 2019
Consult this session to discover PCR London Valves 2019 Closing Ceremony, which gathered over 3000 participants, and learn all about the key moments and what makes this course a wonderful opportunity to enhance your knowledge on transcatheter therapies for valvular heart disease.
Late-Breaking Trials at PCR London Valves 2019 - Session 2
18 Nov 2019 – From PCR London Valves 2019
View this session from PCR London Valves 2019 presenting late-breaking trials on incidence, predictors and outcome of structural valve deterioration in transcatheter vs. SAVR, and percutaneous edge-to-edge repair for tricuspid regurgitation.
TAVI in patients with associated disease of the aorta
19 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI in patients with associated disease of the aorta to discover various challenging clinical cases: transapical revalving in type B aortic dissection, abdominal aortic rupture treatment during TAVI, double TEVAR for aortic aneurysm and type A aortic dissection, and more!
Treatment options for valvular and paravalvular mitral regurgitation - Hosted by Italy and Switzerland
18 Nov 2019 – From PCR London Valves 2019
Consult this session to discover various treatment options for valvular and paravalvular mitral regurgitation, with challenging cases such as: percutaneous closure of a paraprosthetic mitral valve leak in a high-risk patient with heart failure and haemolytic anaemia, transcatheter paravalvular leak closure in radiolucent mitral bioprosthesis, SAPIEN 3...
Novel transcatheter solutions in unusual clinical scenarios
19 Nov 2019 – From PCR London Valves 2019
Consult this session to discover novel transcatheter solutions in unusual clinical scenarios, with clinical cases such as Inoue balloon for retrograde balloon aortic valvuloplasty, peri-procedural transient ST elevation during LAA closure, and more!
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction
03 Apr 2022
Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.
Author
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial
09 Nov 2022
Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.
Author
